MKP-1 modulates ubiquitination/phosphorylation of TLR signaling

Jaya Talreja1, Christian Bauerfeld2, Xiantao Wang3

  • 1Department of Medicine, Division of Pulmonary, Critical Care and Sleep Medicine, Wayne State University School of Medicine and Detroit Medical Center, Detroit, MI, USA.

Life Science Alliance
|September 28, 2021
PubMed

Insights

Mitogen-activated protein kinase phosphatase (MKP)-1 deficiency alters deubiquitinase enzymes, impacting immune signaling. Inhibiting USP13 reduces TRAF6 ubiquitination and inflammatory responses.

Area of Science:

  • Immunology
  • Molecular Biology
  • Biochemistry

Background:

  • Mitogen-activated protein kinase (MAPK) phosphatase-1 (MKP-1) is crucial for regulating innate and adaptive immunity.
  • MKP-1's known function involves dephosphorylating p38 and JNK MAPKs.
  • Its broader roles in immune cell regulation are not fully understood.

Purpose of the Study:

  • To investigate the role of MKP-1 in modulating ubiquitin ligases and deubiquitinase enzymes (DUBs).
  • To elucidate the impact of MKP-1 deficiency on IL-1/Toll-like receptor (TLR) signaling pathways.
  • To identify specific DUBs regulated by MKP-1 and their downstream effects.

Main Methods:

  • Comparative analysis of gene and protein expression in wild-type and MKP-1 knockout (MKP-1-/-) murine bone marrow-derived macrophages (BMDMs).
  • Assessment of protein ubiquitination status, particularly K63 polyubiquitination on TRAF6.
  • Pharmacological inhibition of ubiquitin-specific protease-13 (USP13) to evaluate its effect on signaling pathways and cytokine production.

Main Results:

  • MKP-1 deficiency leads to aberrant regulation of DUBs and increased expression of IL-1/TLR signaling components.
  • MKP-1-/- BMDMs exhibit enhanced K63 polyubiquitination on TRAF6 and increased TAK1 phosphorylation.
  • USP13 expression is substantially enhanced in MKP-1-deficient BMDMs, and its inhibition reduces TRAF6 ubiquitination and inflammatory cytokine induction.

Conclusions:

  • MKP-1 influences the ubiquitin ligase activity of TRAF6 through the modulation of specific DUBs, notably USP13.
  • This study reveals a novel mechanism by which MKP-1 controls inflammatory signaling pathways.
  • Targeting USP13 may represent a therapeutic strategy for inflammatory conditions associated with MKP-1 dysregulation.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.2K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.3K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
6.5K
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.7K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.9K
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
8.0K